Chris Washburn, PhD | November 18, 2011
K.V. Narayanan Menon, MD, staff clinician, Cleveland Clinic, describes the Cleveland Clinic's multidisciplinary approach to managing patients with liver cancer. "The concept is a one-stop shop where patients get to see all of the necessary individuals needed for their care in one way and in one place," said Menon.
Bret Lashner, MD, MPH, FACG, shares his thoughts about the first day of the 47th Annual Gastroenterology Update at the Cleveland Clinic, including the recent developments with inflammatory bowel disease and hepatitis C therapy.
Ahmed Kandiel, MD, MPH, kicked off the 47th Annual Gastroenterology Update with a thorough review of the current treatment landscape for moderate to severe inflammatory bowel disease, including the potential risks for side effects for each biologic agent.
"IL-28B receptor polymorphism is an important predictor of SVR in patients treated with pegylated interferon and ribavirin," said Binu John, MD at the Cleveland Clinic.